NCT00158782
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Rotterdam, Netherlands
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,040 public trials
1,178 recruiting studies
Adenocarcinoma trial results
NCT00363194
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Detroit, Michigan, United States
NCT00478725
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT00370513
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Hong Kong
- GSK Investigational Site Taipei, Taiwan
NCT01266837
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Charitè Campus Benjamin Franklin Berlin, Germany
- Klinik und Poliklinik für Urologie , Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
- Urologie - Waldkrankenhaus St. Marien Erlangen, Germany
- Klinik für Innere Medizin (Tumorforschung), Universitätsklinikum Essen Essen, Germany
Completed
VEG111485: A QTc Study of Pazopanib
NCT00861029
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Duarte, California, United States
- GSK Investigational Site Santa Monica, California, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
NCT00278395
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00401583
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Singapore
NCT00516672
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Saitama, Japan
Completed
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
NCT00666978
- Conditions
- Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +78 more
- Locations
-
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States
- Swope Health Central Kansas City, Missouri, United States